Advances in differential diagnosis and management of growth hormone deficiency in children

Area of Science:

• Pediatric Endocrinology
• Growth Hormone Biology
• Pituitary Disorders

Background:

• Growth hormone (GH) deficiency (GHD) in children impairs pituitary GH production, leading to growth failure.
• GHD can be congenital or acquired, presenting in isolation or with other pituitary hormone deficiencies.
• Prevalence of isolated GHD is estimated at 1 in 4000–10,000 live births, with some causes remaining unknown.

Purpose of the Study:

• To review the differential diagnosis of GHD in children, including clinical presentation, neuroimaging, and genetic testing.
• To highlight advances and challenges in GHD management, focusing on transitional care from childhood to adulthood.
• To emphasize the importance of accurate diagnosis for initiating recombinant human GH therapy to achieve optimal adult height.

Main Methods:

• Review of current literature on pediatric growth hormone deficiency.
• Analysis of diagnostic approaches including clinical evaluation, neuroimaging, and genetic testing.
• Examination of treatment strategies and transitional care protocols for GHD.

Main Results:

• Accurate diagnosis is crucial for effective treatment with recombinant human GH, enabling children to reach their genetically determined adult height.
• Understanding the benefits of GH therapy during the transition period from childhood to adulthood has increased.
• Improved transitional care can mitigate physical and psychological issues associated with adult GHD.

Conclusions:

• Timely diagnosis and treatment of GHD in children with recombinant human GH are essential for achieving optimal growth outcomes.
• Continued research into the causes and management of GHD is necessary.
• Enhanced transitional care strategies are vital for improving the long-term well-being of individuals with GHD.